影像学评估方法在进展期胃癌新辅助化学治疗后的研究现状  

Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer

作　　者：邱礼杰 王海斌 QIU Lijie;WANG Haibin(Clinical College of Guizhou Medical University,Guiyang 550000,China;Department of Gastrointestinal Surgery,Affiliated Hospital of Guizhou Medical University,Guiyang 550000,China)

机构地区：[1]贵州医科大学临床医学院,贵州贵阳550000 [2]贵州医科大学附属医院胃肠外科,贵州贵阳550000

出　　处：《医学影像学杂志》2022年第9期1584-1587,共4页Journal of Medical Imaging

摘　　要：新辅助化学治疗在局部进展期胃癌患者中的总体疗效已经得到证实,其疗效评估的金标准仍然是术后病理缓解程度,但进行新辅助化学治疗后,通过对短期的化学治疗疗效的评估,及时总结及调整治疗方案对患者的手术效果与预后尤为重要。新辅助化学治疗后短期的疗效评估到目前并无统一定论,本文就影像学方法在进展期胃癌新辅助化学治疗后的疗效评估进行综述。The overall efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer has been confirmed,and the gold standard for efficacy evaluation is still the degree of postoperative pathological remission.However,after neoadjuvant chemotherapy,it is particularly important to timely summarize and adjust the treatment plan for the surgical effect and prognosis of patients through the evaluation of short-term chemotherapy efficacy.However,the short-term efficacy evaluation after neoadjuvant chemotherapy has not been unified.This paper reviews the imaging evaluation of neoadjuvant chemotherapy for advanced gastric cancer.

关 键 词：胃癌 新辅助治疗 化学治疗 疗效 影像学 

分 类 号：R735.2[医药卫生—肿瘤] R815[医药卫生—临床医学]